JPMorgan Says Mylan Has 3 Paths To Upside By: Benzinga via Benzinga April 08, 2015 at 11:04 AM EDT In a report published Wednesday, JPMorgan analyst Chris Schott shared his thoughts on Mylan NV (NASDAQ: MYL). According to ... Read More >> Related Stocks: Mylan Teva Pharmaceutical Industries ADR